The Current Ratio as of September 2024 (TTM) for Xenetic Biosciences, Inc. (XBIO) is 5.05

According to Xenetic Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.05. This represents a change of -48.37% compared to the average of 9.78 of the last 4 quarters.

Xenetic Biosciences, Inc. (XBIO) Historical Current Ratio (quarterly & annually)

How has XBIO Current Ratio performed in the past?

The mean historical Current Ratio of Xenetic Biosciences, Inc. over the last ten years is 6.86. The current 5.05 Current Ratio has changed 7.26% with respect to the historical average. Over the past ten years (40 quarters), XBIO's Current Ratio was at its highest in in the September 2021 quarter at 18.35. The Current Ratio was at its lowest in in the June 2016 quarter at 0.13.

Xenetic Biosciences, Inc. (XBIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Xenetic Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Xenetic Biosciences, Inc. (XBIO) Average Current Ratio

How has XBIO Current Ratio performed in the past?

The current Current Ratio of Xenetic Biosciences, Inc. (XBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Xenetic Biosciences, Inc. (XBIO) Current Ratio vs. Peers

How is XBIO’s Current Ratio compared to its peers?

Xenetic Biosciences, Inc.’s Current Ratio is greater than TransCode Therapeutics, Inc. (1.25), greater than Landos Biopharma, Inc. (4.43), greater than NexImmune, Inc. (0.66), greater than Oncorus, Inc. (1.50), greater than ZyVersa Therapeutics, Inc. (0.06), less than Immix Biopharma, Inc. (7.00), greater than Phio Pharmaceuticals Corp. (3.47), greater than 180 Life Sciences Corp. (0.58), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Revelation Biosciences, Inc. (1.10), greater than YS Biopharma Co., Ltd. (0.94), greater than GeoVax Labs, Inc. (0.60), greater than NovaBay Pharmaceuticals, Inc. (0.62), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than Palisade Bio, Inc. (4.31), less than Bright Minds Biosciences Inc. (35.08), less than Virax Biolabs Group Limited (25.94), greater than Tonix Pharmaceuticals Holding Corp. (1.15), less than Zura Bio Limited (12.57), greater than Altamira Therapeutics Ltd. (1.38), less than Enveric Biosciences, Inc. (7.37),

Build a custom stock screener for Xenetic Biosciences, Inc. (XBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xenetic Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xenetic Biosciences, Inc. (XBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xenetic Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.